BPLPHARMA vs ZOTA: Stock Comparison

BHARAT PARENTERALS vs ZOTA HEALTH CAREUpdated 17 Sept 26, 12:10 PM ISTNSE & company filings

BHARAT PARENTERALS shows a higher dividend yield and a higher net margin, while ZOTA HEALTH CARE shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BPLPHARMA leads 5; ZOTA leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BPLPHARMAZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
₹3,922 Cr
P/E RatioSame reading
0x
0x
P/B RatioBPLPHARMA has the lower reading
3.18x
5.59x
EPSBPLPHARMA has the higher reading
₹5.31
₹-12.58
Book ValueContext only
₹452.09
₹201.01
Dividend YieldBPLPHARMA has the higher reading
0.13%
0.09%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/B Ratio
BPLPHARMA has a lower P/B
3.18x vs 5.59x
EPS
BPLPHARMA has higher earnings per share
₹5.31 vs ₹-12.58
Dividend Yield
BPLPHARMA has a higher dividend yield
0.13% vs 0.09%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
36.66% vs -40.79%
Qtr Profit Growth
BPLPHARMA has stronger quarterly profit growth
202.63% vs -2,416.29%
Net Margin
BPLPHARMA has a higher net margin
0% vs -13.98%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBPLPHARMAZOTA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricBPLPHARMAZOTA
Live Price₹1,547₹1,130.3
Day Change2.46%1.45%
Volume2348,934
52-Week High₹1,649₹1,740
52-Week Low₹1,125.7₹1,022
Distance from 52W High-6.19%-35.04%

Valuation

MetricBPLPHARMAZOTA
Market Cap₹0 Cr₹3,922 Cr
P/E Ratio0x0x
P/B Ratio3.18x5.59x
EPS₹5.31₹-12.58
Book Value₹452.09₹201.01
Dividend Yield0.13%0.09%

Growth

MetricBPLPHARMAZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-40.79%36.66%
Qtr Profit Growth202.63%-2,416.29%

Profitability & Leverage

MetricBPLPHARMAZOTA
ROE3.14%
ROCE3.76%
Net Margin0%-13.98%
Operating Margin9.83%
Debt to Equity0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBPLPHARMAZOTA
Promoter Holding67.2% 0.03 pp49.38%
FII Holding0.11%7.92% 0.29 pp
DII Holding1.37% 0.31 pp6.75% 0.35 pp
Public Holding31.31% 0.35 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BHARAT PARENTERALS and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.